Stay updated on Long Term Safety of Serlopitant for Pruritus Clinical Trial
Sign up to get notified when there's something new on the Long Term Safety of Serlopitant for Pruritus Clinical Trial page.

Latest updates to the Long Term Safety of Serlopitant for Pruritus Clinical Trial page
- Check6 days agoNo Change Detected
- Check13 days agoChange DetectedRevision label updated from v3.4.1 to v3.4.2. No modifications to study details or page functionality.SummaryDifference0.0%

- Check20 days agoChange DetectedThe page now shows a new revision label v3.4.1 and removes v3.4.0; this appears to be a metadata/version update and does not change the study details or user-facing content. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check27 days agoChange DetectedThe changes are minor UI text updates and a version bump (Show glossary, capitalization adjustments in labels, and revision from v3.3.4 to v3.4.0). To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check42 days agoChange DetectedThe page shows an updated revision label (v3.3.4) replacing the previous revision (v3.3.3).SummaryDifference0.0%

- Check63 days agoChange DetectedThe Locations section now includes a broad list of U.S. study sites (Alabama, California, Florida, Georgia, Illinois, Kentucky, Louisiana, Maryland, Michigan, Missouri, Nebraska, Nevada, New Jersey, New York, North Carolina, Ohio, Oklahoma, Pennsylvania, Rhode Island, South Carolina, Tennessee, Texas, Virginia, Washington, West Virginia). The page revision tag changed from v3.3.2 to v3.3.3.SummaryDifference2%

- Check91 days agoChange DetectedRevision: v3.3.2 is now displayed, replacing the previous Revision: v3.2.0.SummaryDifference0.0%

Stay in the know with updates to Long Term Safety of Serlopitant for Pruritus Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Long Term Safety of Serlopitant for Pruritus Clinical Trial page.